Corcept Therapeutics Incorporated (NASDAQ:CORT) Sees Significant Stock Increase Following Positive Trial Results
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameCorcept Therapeutics Incorporated
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









